Very clever theory. A significant pillar of this theory would have to be knowledge on the part of A/W that they are, in fact, violating MNTA's patent. A/W is the only one who knows their formulation and the various processes that were necessary to perform in order to obtain FDA approval. Accordingly, they already know, if not the outcome of the litigation, at least whether or not MNTA has a strong case.